Results 51 to 60 of about 98,340 (384)

Nanoformulation Development to Improve the Biopharmaceutical Properties of Fisetin Using Design of Experiment Approach

open access: yesMolecules, 2021
This study aimed to design an effective nanoparticle-based carrier for the oral delivery of fisetin (FST) with improved biopharmaceutical properties. FST-loaded nanoparticles were prepared with polyvinyl alcohol (PVA) and poly(lactic-co-glycolic acid ...
Wan-Yi Liu   +3 more
semanticscholar   +1 more source

Assessing the Immunogenicity of Biopharmaceuticals [PDF]

open access: yesBioDrugs, 2016
Biopharmaceuticals have the potential to raise an immunogenic response in treated individuals, which may impact the efficacy and safety profile of these drugs. As a result, it is essential to evaluate immunogenicity throughout the different phases of the clinical development of a biopharmaceutical, including post-marketing surveillance.
Carlos Pineda   +4 more
openaire   +2 more sources

The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange

open access: yesAntibodies, 2019
The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various ...
Felix Kuhne   +9 more
doaj   +1 more source

Polyphosphazenes for the delivery of biopharmaceuticals [PDF]

open access: yesJournal of Applied Polymer Science, 2019
ABSTRACTPolyphosphazenes (PPZs) are a relatively new family of polymers based on a nitrogen–phosphorous backbone where organic side groups can be grafted. The synthetic route to PPZs is highly versatile such that it is possible to add many different functionalities that change completely the physicochemical and biological properties of the polymers ...
Wei-Hsin Hsu   +4 more
openaire   +3 more sources

Hydrophilic Monomethyl Auristatin E Derivatives as Novel Candidates for the Design of Antibody-Drug Conjugates

open access: yesSeparations, 2018
Antibody-drug conjugates (ADCs) are promising state-of-the-art biopharmaceutical drugs for selective drug-delivery applications and the treatment of diseases such as cancer.
Filip S. Ekholm   +8 more
doaj   +1 more source

Glyco-Engineering Plants to Produce Helminth Glycoproteins as Prospective Biopharmaceuticals: Recent Advances, Challenges and Future Prospects

open access: yesFrontiers in Plant Science, 2022
Glycoproteins are the dominant category among approved biopharmaceuticals, indicating their importance as therapeutic proteins. Glycoproteins are decorated with carbohydrate structures (or glycans) in a process called glycosylation.
Alex van der Kaaij   +4 more
doaj   +1 more source

Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review

open access: yesProcesses, 2020
The development and application of emerging technologies of Industry 4.0 enable the realization of digital twins (DT), which facilitates the transformation of the manufacturing sector to a more agile and intelligent one.
Yingjie Chen   +5 more
semanticscholar   +1 more source

A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest

open access: yesJournal of Law, Medicine & Ethics, 2021
Enhancing research and development and ensuring equitable pricing and access to cutting-edge treatments are both vital to a biopharmaceutical innovation system that works in the public interest.
M. Mazzucato, Henry Lishi Li
semanticscholar   +1 more source

Biopharmaceuticals in China

open access: yesBiotechnology Journal, 2006
AbstractThe biopharmaceutical industry, whose products are produced mainly by recombinant DNA technology, antibody technologies and cytotechnology, is the most important sector in industrial biotechnology, and is one of the most rapidly growing high‐tech industries.
Xianwen Hu, Shuyong Zhang, Qingjun Ma
openaire   +4 more sources

Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production

open access: yesPlants, 2020
The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing steadily, which is attracting global attention for the development of new recombinant protein production technologies and the engineering of conventional ...
B. Shanmugaraj   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy